Shah H, Patel P, Nath A, Shah U, Sarkar R
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40072555
DOI: 10.1007/s00210-025-03957-8.
Concepcion C, Xia Y, Korshunova Y, Bligard G, Taylor A, Paley M
iScience. 2025; 28(3):111928.
PMID: 40060903
PMC: 11889669.
DOI: 10.1016/j.isci.2025.111928.
Jeng L, Shih F, Liao Y, Shyu W, Teng C
Br J Cancer. 2025; .
PMID: 40050434
DOI: 10.1038/s41416-025-02975-w.
Chen Z, Yu T, Wang Y, Li J, Zhang B, Zhou L
Front Oncol. 2025; 14:1443686.
PMID: 39906672
PMC: 11790455.
DOI: 10.3389/fonc.2024.1443686.
Mohamedali K, Aguirre B, Lu C, Chandla A, Kejriwal N, Liu L
J Immunother Cancer. 2025; 12(12.
PMID: 39794935
PMC: 11667298.
DOI: 10.1136/jitc-2024-008891.
Genetically Predicted Immune Cell Traits Mediate the Causal Association Between Plasma Metabolites and Colorectal Cancer.
Zhu L, Ning Q, Xue J, Huang S, Chen X, Qiu X
J Cancer. 2025; 16(2):430-444.
PMID: 39744475
PMC: 11685676.
DOI: 10.7150/jca.101011.
A biomathematical model of SARS-CoV-2 in Syrian hamsters.
Schirm S, Nouailles G, Kirsten H, Trimpert J, Wyler E, Teixeira Alves L
Sci Rep. 2024; 14(1):30541.
PMID: 39695178
PMC: 11655638.
DOI: 10.1038/s41598-024-80498-9.
Deficiencies of Inducible Costimulator (ICOS) During Chronic Infection with Upregulate the CD28-Dependent Cytotoxicity of CD8 T Cells and Their Effector Function Against Tissue Cysts of the Parasite.
Mani R, Balu K, Suzuki Y
Cells. 2024; 13(23).
PMID: 39682747
PMC: 11640114.
DOI: 10.3390/cells13231998.
Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy.
Logun M, Wang X, Sun Y, Bagley S, Li N, Desai A
Cell Stem Cell. 2024; 32(2):181-190.e4.
PMID: 39657679
PMC: 11808387.
DOI: 10.1016/j.stem.2024.11.010.
Targeting macrophage migration inhibitory factor to inhibit T cell immunosuppression in the tumor microenvironment and improve cancer outcomes in head and neck squamous cell carcinoma.
Pracha S, Shrestha S, Ryan N, Upadhaya P, Lamenza F, Jagadeesha S
Oral Oncol. 2024; 160():107126.
PMID: 39644862
PMC: 11723708.
DOI: 10.1016/j.oraloncology.2024.107126.
Cabozantinib inhibits tumor growth in mice with ovarian cancer.
Stiff P, Kertowidjojo E, Potkul R, Banerjee S, Mehrotra S, Small Jr W
Am J Cancer Res. 2024; 14(10):4788-4802.
PMID: 39553221
PMC: 11560812.
DOI: 10.62347/ZSWV1767.
Granzyme mRNA-miRNA interaction and its implication to functional impact.
Kim H, Kim J, Shin Y
Genes Genomics. 2024; 46(12):1495-1506.
PMID: 39528794
DOI: 10.1007/s13258-024-01578-8.
Antibody-targeted T cells and natural killer cells for cancer immunotherapy.
Sutherland A, Parlekar B, Livingstone D, Medina A, Bernhard W, Garcia T
J Nanobiotechnology. 2024; 22(1):640.
PMID: 39425222
PMC: 11488284.
DOI: 10.1186/s12951-024-02898-3.
Recent advances in targeted drug delivery systems for multiple myeloma.
Pant A, Laliwala A, Holstein S, Mohs A
J Control Release. 2024; 376:215-230.
PMID: 39384153
PMC: 11611669.
DOI: 10.1016/j.jconrel.2024.10.003.
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer.
Mustafa M, Abbas K, Alam M, Habib S, Zulfareen , Hasan G
Front Oncol. 2024; 14:1427802.
PMID: 39087024
PMC: 11288929.
DOI: 10.3389/fonc.2024.1427802.
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective.
Bakhtiyaridovvombaygi M, Yazdanparast S, Kheyrandish S, Safdari S, Amiri Samani F, Sohani M
Biomark Res. 2024; 12(1):66.
PMID: 39020411
PMC: 11253502.
DOI: 10.1186/s40364-024-00610-z.
Bacterial vaginosis-driven changes in cervicovaginal immunity that expand the immunological hypothesis for increased HIV susceptibility.
MacLean F, Tsegaye A, Graham J, Swarts J, Vick S, Potchen N
bioRxiv. 2024; .
PMID: 39005354
PMC: 11245000.
DOI: 10.1101/2024.07.03.601916.
Peripheral Blood CD8 T-Lymphocyte Immune Response in Benign and Subpopulations of Breast Cancer Patients.
Lenart M, Bober P, Marcin M, Tkacikova S, Kacirova M, Alexovic M
Int J Mol Sci. 2024; 25(12).
PMID: 38928129
PMC: 11204132.
DOI: 10.3390/ijms25126423.
Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis.
Zhao A, Unterman A, Abu Hussein N, Sharma P, Nikola F, Flint J
Am J Respir Crit Care Med. 2024; 210(10):1252-1266.
PMID: 38924775
PMC: 11568434.
DOI: 10.1164/rccm.202401-0078OC.
Radiotherapy and immunology.
Wang L, Lynch C, Pitroda S, Piffko A, Yang K, Huser A
J Exp Med. 2024; 221(7).
PMID: 38771260
PMC: 11110906.
DOI: 10.1084/jem.20232101.